Insider · CIK 0001726884
Todd W Garner
Files at CNMD (CONMED Corp), AVTR (Avantor, Inc.). First filing Aug 8, 2025, latest Nov 7, 2025.
Todd W Garner files SEC Form 4 as CFO at CNMD (CONMED Corp), and also at AVTR (Avantor, Inc.). Since Aug 8, 2025, Todd W Garner has reported 0 open-market buys worth $0 and 2 open-market sells worth $182k, the latest filed on Nov 7, 2025.
A track record needs three past buys with six months of prices behind them; Todd W Garner has 0, so none is measured yet.
The newest scored trade: sold $151k of CNMD on Nov 6, 2025, filed Nov 7, 2025, scored 33 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $151k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CNMD: CONMED Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | CONMED Corp | $151k 3,500 shares | -66% | +4% from low-42% from high | |
| 47Moderate | CNMDsell CONMED Corp | $31k 598 shares | -100% | +12% from low-30% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 6, 2025 | CNMD CONMED Corp | 3,500 0.01% of outstanding | $151k | Nov 6, 2025 | $31k |
| Aug 7, 2025 | CNMD CONMED Corp | 598 0.00% of outstanding | $31k | Aug 7, 2025 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | AVTR Avantor, Inc. | AGrant or award Common Stock | +49,688 | $0.00 | $0 | 49,688 | 20 d ago |
| Sep 21, 2026 | AVTR Avantor, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +138,632 | $0.00 | $0 | 138,632 | 20 d ago |
| Nov 6, 2025 | CNMD CONMED Corp | SOpen-market sale Common Stock10b5-1 | -3,500 | $43.00 | $151k | 1,836 | Nov 7, 2025 |
| Oct 31, 2025 | CNMD CONMED Corp | MOption exercise Common Stock | +7,500 | $0.00 | $0 | 7,500 | Nov 3, 2025 |
| Oct 31, 2025 | CNMD CONMED Corp | FTax withholding Common Stock | -2,164 | $44.00 | $95k | 5,336 | Nov 3, 2025 |
| Oct 31, 2025 | CNMD CONMED Corp | MOption exercise RSUs (Restricted Stock Units)derivative | -7,500 | $0.00 | $0 | 15,227 | Nov 3, 2025 |
| Aug 7, 2025 | CNMD CONMED Corp | SOpen-market sale Common Stock | -598 | $52.45 | $31k | 0 | Aug 8, 2025 |
| Mar 31, 2025 | CNMD CONMED Corp | AGrant or award Common Stock | +371 | $57.37 | $21k | 598 | Apr 8, 2025 |
| Mar 3, 2025 | CNMD CONMED Corp | AGrant or award Options To Purchase Common Stockderivative | +61,475 | $0.00 | $0 | 61,475 | Mar 5, 2025 |
| Nov 1, 2024 | CNMD CONMED Corp | AGrant or award RSUs (Restricted Stock Units)derivative | +22,727 | $0.00 | $0 | 22,727 | Nov 5, 2024 |
Questions about Todd W Garner
Answered from the filings on this page, as of the latest one.
Is Todd W Garner buying or selling?
In the last 12 months Todd W Garner reported 0 open-market buys worth $0 and 1 open-market sell worth $151k on SEC Form 4; the latest was sold $151k of CNMD on Nov 6, 2025. Grants, option exercises and tax withholding are not counted.
How did Todd W Garner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Todd W Garner has 0.
Where does Todd W Garner file Form 4?
Todd W Garner has filed Form 4 at CNMD (CONMED Corp) as Executive Vice President & CFO; AVTR (Avantor, Inc.) as EVP and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.